(PharmaNewsWire.Com, February 22, 2018 ) The IVCF is a type of vascular filter that is inserted into the inferior vena cava to prevent blood clots from moving from the veins in the legs and pelvis to the lung, which can lead to life-threatening pulmonary embolism (PE). Publisher's analysts forecast the global inferior vena cava (IVC) filters market to grow at a CAGR of 11.24% during the period 2018-2022.
Covered in this report The report covers the present scenario and the growth prospects of the global inferior vena cava (IVC) filters market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Key questions answered in this report: -What will the market size be in 2022 and what will the growth rate be- -What are the key market trends- -What is driving this market- -What are the challenges to market growth- -Who are the key vendors in this market space-
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: